European Medicines Evaluation Agency (emea) - EMEA press release - European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents (ID - humtop)

This content is available to DeHavilland subscribers only

For more information on our services or to request a limited FREE TRIAL, please visit our website

Please note: This is not an instant access service; DeHavilland services are tailored to the specific needs of each client. For any other queries please send us an email

DeHavilland - the leading UK parliamentary monitoring and political research service.

DeHavilland provides a wide range of political news and information centred on the UK and European agenda.

Our information keeps leading organisations informed of the latest parliamentary developments which have a direct impact on their public affairs, government relations and communications objectives.